JPH09503905A
(ja)
|
1993-07-15 |
1997-04-22 |
ネオゼ ファーマシューティカルス |
糖組成物の合成方法
|
US6495348B1
(en)
|
1993-10-07 |
2002-12-17 |
Regents Of The University Of Minnesota |
Mitomycin biosynthetic gene cluster
|
US6524812B1
(en)
|
1993-10-07 |
2003-02-25 |
Regents Of The University Of Minnesota |
Genes encoding resistance to DNA alkylating agents
|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
US6127153A
(en)
*
|
1995-06-07 |
2000-10-03 |
Neose Technologies, Inc. |
Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
|
US6600029B1
(en)
|
1995-12-19 |
2003-07-29 |
Regents Of The University Of Minnesota |
Metabolic engineering of polyhydroxyalkanoate monomer synthases
|
US6096529A
(en)
|
1996-06-10 |
2000-08-01 |
National Research Council Of Canada |
Recombinant α-2,3-sialyltransferases and their uses
|
JP2001503274A
(ja)
*
|
1996-11-08 |
2001-03-13 |
サイテル コーポレイション |
改良された発現ベクター
|
US5945314A
(en)
*
|
1997-03-31 |
1999-08-31 |
Abbott Laboratories |
Process for synthesizing oligosaccharides
|
US6045854A
(en)
*
|
1997-03-31 |
2000-04-04 |
Abbott Laboraties |
Nutritional formulations containing oligosaccharides
|
US5906982A
(en)
*
|
1997-03-31 |
1999-05-25 |
Abbott Laboratories |
Nutritional formulations containing Lacto-N-neoTetraose
|
US5968809A
(en)
|
1997-04-11 |
1999-10-19 |
Abbot Laboratories |
Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
|
US5972664A
(en)
|
1997-04-11 |
1999-10-26 |
Abbott Laboratories |
Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
|
US7745694B1
(en)
|
1997-04-11 |
2010-06-29 |
Monsanto Technology Llc |
Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
|
US6075183A
(en)
*
|
1997-04-11 |
2000-06-13 |
Abbott Laboratories |
Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
|
US6051754A
(en)
*
|
1997-04-11 |
2000-04-18 |
Abbott Laboratories |
Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
|
US6096725A
(en)
*
|
1997-07-02 |
2000-08-01 |
Neose Technologies, Inc. |
Methods of using αGal oligosaccharides as immune system targeting agents
|
JPH11221079A
(ja)
|
1998-02-04 |
1999-08-17 |
Kyowa Hakko Kogyo Co Ltd |
糖転移酵素および該酵素をコードするdna
|
US6689604B1
(en)
|
1998-03-20 |
2004-02-10 |
National Research Council Of Canada |
Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses
|
EP1066388A2
(de)
|
1998-03-25 |
2001-01-10 |
GVS Gesellschaft für Erwerb und Verwertung Landwirtschaftlicher Pflanzensorten MBH |
Prozessive glycosyltransferase
|
PT1086236E
(pt)
|
1998-06-12 |
2007-12-12 |
Calgene Llc |
Ácidos gordos poliinsaturados em plantas
|
US6265202B1
(en)
|
1998-06-26 |
2001-07-24 |
Regents Of The University Of Minnesota |
DNA encoding methymycin and pikromycin
|
FR2780413B1
(fr)
*
|
1998-06-29 |
2003-03-21 |
Centre Nat Rech Scient |
Enzymes a activite alpha-galactosyltransferase de cellules d'insectes, et leurs utilisations
|
US6897052B1
(en)
*
|
1998-08-07 |
2005-05-24 |
Glycodesign Holdings Ltd. |
N-acetylglycosaminyl transferase genes
|
WO2000012747A1
(en)
*
|
1998-08-31 |
2000-03-09 |
Kurt Nilsson |
Method for enzymatic synthesis of glycosides, disaccharides, and oligosaccharides
|
US20030163845A1
(en)
*
|
1998-09-02 |
2003-08-28 |
Pradip Mukerji |
Elongase genes and uses thereof
|
US6403349B1
(en)
|
1998-09-02 |
2002-06-11 |
Abbott Laboratories |
Elongase gene and uses thereof
|
EP1131415A4
(de)
*
|
1998-11-18 |
2002-09-11 |
Neose Technologies Inc |
Kostengünstige herstellung von oligosacchariden
|
US7820393B2
(en)
|
1999-01-14 |
2010-10-26 |
Scantibodies Laboratory, Inc. |
Methods, kits and antibodies for detecting parathyroid hormone
|
US6689566B1
(en)
*
|
1999-01-14 |
2004-02-10 |
Scantibodies Laboratory, Inc. |
Methods, kits, and antibodies for detecting parathyroid hormone
|
US6503744B1
(en)
|
1999-02-01 |
2003-01-07 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
US6699705B2
(en)
*
|
1999-02-01 |
2004-03-02 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
CA2374235A1
(en)
*
|
1999-05-18 |
2000-11-23 |
University Of Iowa Research Foundation |
Production of complex carbohydrates
|
FR2796082B1
(fr)
|
1999-07-07 |
2003-06-27 |
Centre Nat Rech Scient |
Procede de production d'oligosaccharides
|
US7070970B2
(en)
|
1999-08-23 |
2006-07-04 |
Abbott Laboratories |
Elongase genes and uses thereof
|
AUPQ275799A0
(en)
*
|
1999-09-10 |
1999-10-07 |
Luminis Pty Limited |
Recombinant bacterium expressing an oligosaccharide receptor mimic
|
US6518037B2
(en)
*
|
1999-11-12 |
2003-02-11 |
University Of Iowa Research Foundation |
Two-component system that controls bacterial membrane synthesis
|
CA2399860A1
(en)
|
2000-02-11 |
2001-08-16 |
Glycozym Aps |
Udp-galactose: .beta.-d-galactose-r 4-.alpha.-d-galactosyltransferase, .alpha.4gal-t1
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
EP2322644A1
(de)
|
2000-06-28 |
2011-05-18 |
GlycoFi, Inc. |
Verfahren für die Herstellung modifizierter Glykoproteine
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
US20030194784A1
(en)
*
|
2001-04-17 |
2003-10-16 |
Sherman David H. |
DNA encoding methymycin and pikromycin
|
CA2456725A1
(en)
|
2001-08-17 |
2003-02-27 |
Neose Technologies, Inc. |
Chemo-enzymatic synthesis of sialylated oligosaccharides
|
CA2459040A1
(en)
*
|
2001-09-14 |
2003-03-27 |
Mimeon, Inc. |
Methods of making glycolmolecules with enhanced activities and uses thereof
|
DK1578771T3
(da)
*
|
2001-10-10 |
2013-06-10 |
Novo Nordisk As |
Remodellering og glycokonjugering af peptider
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
EP2322229B1
(de)
|
2001-10-10 |
2016-12-21 |
Novo Nordisk A/S |
Neumodulierung und Glykokonjugation von Faktor IX
|
US7265085B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7226903B2
(en)
*
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7439043B2
(en)
*
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7125843B2
(en)
*
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
US20060034854A1
(en)
|
2002-08-02 |
2006-02-16 |
Berthet Francois-Xavier J |
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
NZ567841A
(en)
|
2003-03-06 |
2010-01-29 |
Seneb Biosciences Inc |
Methods and compositions for the enzymatic synthesis of gangliosides
|
NZ542094A
(en)
|
2003-03-14 |
2008-12-24 |
Neose Technologies Inc |
Branched polymer conjugates comprising a peptide and water-soluble polymer chains
|
US7691603B2
(en)
*
|
2003-04-09 |
2010-04-06 |
Novo Nordisk A/S |
Intracellular formation of peptide conjugates
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
SG155777A1
(en)
|
2003-04-09 |
2009-10-29 |
Neose Technologies Inc |
Glycopegylation methods and proteins/peptides produced by the methods
|
WO2006127896A2
(en)
*
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
WO2007022512A2
(en)
*
|
2005-08-19 |
2007-02-22 |
Neose Technologies, Inc. |
Glycopegylated factor vii and factor viia
|
EP1624847B1
(de)
|
2003-05-09 |
2012-01-04 |
BioGeneriX AG |
Zusammensetzungen und Verfahren zur Herstellung von Glykosylierungsmutanten des menschlichen Wachstumshormons
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
WO2005021761A1
(en)
|
2003-08-21 |
2005-03-10 |
Monsanto Technology Llc |
Fatty acid desaturases from primula
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US7405198B2
(en)
*
|
2003-11-24 |
2008-07-29 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20080305992A1
(en)
*
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
*
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
ES2422187T3
(es)
*
|
2003-12-03 |
2013-09-09 |
Biogenerix Ag |
Factor estimulante de colonias de granulocitos glicopegilados
|
JP5236189B2
(ja)
|
2003-12-05 |
2013-07-17 |
チルドレンズ ホスピタル メディカル センター |
オリゴ糖組成物および感染症の治療における該組成物の使用
|
EP1765853B1
(de)
*
|
2004-01-08 |
2015-10-28 |
ratiopharm GmbH |
O-Glykosylierung von G-CSF Peptiden
|
NZ548893A
(en)
|
2004-02-04 |
2009-09-25 |
Biogernerix Ag |
Methods of refolding mammalian glycosyltransferases
|
EP1734947B1
(de)
|
2004-04-16 |
2015-04-15 |
Monsanto Technology, LLC |
Expression von fettsäuredesaturasen in mais
|
RU2006138181A
(ru)
*
|
2004-05-04 |
2008-06-10 |
Ново Нордиск Хелс Кеа Аг (Ch) |
О-связанные гликоформы полипептидов и способ их изготовления
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
WO2006020372A2
(en)
*
|
2004-07-23 |
2006-02-23 |
Neose Technologies, Inc. |
Enzymatic modification of glycopeptides
|
WO2006031811A2
(en)
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
US20080108557A1
(en)
*
|
2004-09-29 |
2008-05-08 |
Novo Nordisk Healthcare A/G |
Modified Proteins
|
EP3061461A1
(de)
*
|
2004-10-29 |
2016-08-31 |
ratiopharm GmbH |
Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
|
EP1838332A1
(de)
*
|
2005-01-06 |
2007-10-03 |
Neose Technologies, Inc. |
Glycokonjugation über saccharylfragmente
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
WO2006105426A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Neose Technologies, Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
WO2006121569A2
(en)
*
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
US20110003744A1
(en)
*
|
2005-05-25 |
2011-01-06 |
Novo Nordisk A/S |
Glycopegylated Erythropoietin Formulations
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
WO2007056191A2
(en)
*
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
CA2654709A1
(en)
|
2006-06-12 |
2007-12-21 |
Nathalie Devos |
Neisseria meningitidis lipooligosaccharide vaccine
|
EP2041275B1
(de)
|
2006-07-19 |
2011-05-04 |
Monsanto Technology, LLC |
Fettsäuredesaturasen aus tetraselmis suecica
|
US20080274958A1
(en)
*
|
2006-07-21 |
2008-11-06 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
MX2009003470A
(es)
*
|
2006-10-04 |
2009-04-14 |
Novo Nordisk As |
Azucares y glicopeptidos pegilados enlazados a glicerol.
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
NZ580030A
(en)
|
2007-04-03 |
2012-06-29 |
Biogenerix Ag |
Methods of treatment using glycopegylated g-csf
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
US20110177029A1
(en)
*
|
2007-06-04 |
2011-07-21 |
Novo Nordisk A/S |
O-linked glycosylation using n-acetylglucosaminyl transferases
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
US7968811B2
(en)
*
|
2007-06-29 |
2011-06-28 |
Harley-Davidson Motor Company Group, Inc. |
Integrated ignition and key switch
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
CN102037004A
(zh)
*
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|
KR101582841B1
(ko)
|
2008-02-27 |
2016-01-11 |
노보 노르디스크 에이/에스 |
콘쥬게이트된 인자 viii 분자
|
AU2010236721B2
(en)
|
2009-04-13 |
2015-03-12 |
Children's Hospital Medical Center |
Milk oligosaccharide compositions and use thereof in treating infection in animals
|
DK2451462T3
(en)
|
2009-07-06 |
2017-12-11 |
Children's Hospital Medical Center |
Inhibition of inflammation with milk oligosaccharides
|
CN102869784A
(zh)
|
2010-04-07 |
2013-01-09 |
动量制药公司 |
高甘露糖聚糖
|
EP2454948A1
(de)
|
2010-11-23 |
2012-05-23 |
Nestec S.A. |
Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung
|
EP2465507A1
(de)
|
2010-11-23 |
2012-06-20 |
Nestec S.A. |
Oligosaccharid Zusammensetzung zur Behandlung von Hautkrankheiten
|
EP2465509A1
(de)
|
2010-11-23 |
2012-06-20 |
Nestec S.A. |
Oligosaccharid Zusammensetzung zur Behandlung von akuten Atemwegsinfektionen
|
EP2465508A1
(de)
|
2010-11-23 |
2012-06-20 |
Nestec S.A. |
Zusammensetzung mit hydrolysierten Proteinen und Oligosacchariden zur Behandlung von Hautkrankheiten
|
US10130587B2
(en)
|
2011-01-11 |
2018-11-20 |
Capsugel Belgium Nv |
Hard capsules
|
WO2012125553A2
(en)
|
2011-03-12 |
2012-09-20 |
Momenta Pharmaceuticals, Inc. |
N-acetylhexosamine-containing n-glycans in glycoprotein products
|
PT2768313E
(pt)
|
2011-10-18 |
2015-10-14 |
Nestec Sa |
Complexos de derivados de hidratos de carbono-ferro hidrossolúveis, a sua produção e os medicamentos que os contêm
|
US20140271562A1
(en)
|
2011-10-18 |
2014-09-18 |
Nestec S.A. |
Composition for use in brain growth and/or cognitive and/or psychomotor development
|
US9662358B2
(en)
|
2011-10-18 |
2017-05-30 |
Nestec S.A. |
Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease
|
EP2768311B1
(de)
|
2011-10-18 |
2018-02-21 |
Nestec S.A. |
Zusammensetzung zur verwendung bei der förderung der intestinalen angiogenese und der nährstoffabsorption und der enteralen ernährungstoleranz und/oder bei der prävention und/oder behandlung von darmentzündung und/oder bei der erholung nach darmverletzungen und -operationen
|
ES2560023T3
(es)
|
2011-10-18 |
2016-02-17 |
Nestec S.A. |
Composición para su uso para incrementar la sensibilidad a la insulina y / o para reducir la resistencia a la insulina
|
US9695244B2
(en)
|
2012-06-01 |
2017-07-04 |
Momenta Pharmaceuticals, Inc. |
Methods related to denosumab
|
TWI510627B
(zh)
*
|
2012-08-20 |
2015-12-01 |
Academia Sinica |
寡醣之大規模酵素合成
|
WO2014149067A1
(en)
|
2013-03-15 |
2014-09-25 |
Momenta Pharmaceuticals, Inc. |
Methods related to ctla4-fc fusion proteins
|
WO2014186310A1
(en)
|
2013-05-13 |
2014-11-20 |
Momenta Pharmaceuticals, Inc. |
Methods for the treatment of neurodegeneration
|
WO2015057622A1
(en)
|
2013-10-16 |
2015-04-23 |
Momenta Pharmaceuticals, Inc. |
Sialylated glycoproteins
|
CN105722514A
(zh)
|
2013-11-15 |
2016-06-29 |
雀巢产品技术援助有限公司 |
用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
|
ES2857077T3
(es)
|
2013-11-15 |
2021-09-28 |
Nestle Sa |
Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo
|
ES2895380T3
(es)
|
2013-11-15 |
2022-02-21 |
Nestle Sa |
Composiciones para su uso en la prevención o tratamiento de la enterocolitis necrotizante en bebés y niños pequeños
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
MX2017010923A
(es)
|
2015-03-05 |
2018-01-16 |
Nestec Sa |
Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
|
CN107427054A
(zh)
|
2015-03-05 |
2017-12-01 |
雀巢产品技术援助有限公司 |
用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
|
DE202016008919U1
(de)
|
2015-03-05 |
2020-09-07 |
Société des Produits Nestlé S.A. |
Zusammensetzungen zur Verwendung bei der Prävention oder Behandlung von gastrointestinalen Infektionen/Entzündungen bei Säuglingen oder Kleinkindern
|
CN109562117A
(zh)
|
2016-08-04 |
2019-04-02 |
雀巢产品技术援助有限公司 |
具有2FL和LNnT的营养组合物,用于通过作用于肠道微生物群生态失调来预防和/或治疗非轮状病毒腹泻
|
WO2018046311A1
(en)
|
2016-09-07 |
2018-03-15 |
Nestec S.A. |
Nutritional compositions for infants and/or young children comprising oligosaccharides
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
US11576870B2
(en)
|
2017-04-14 |
2023-02-14 |
Capsugel Belgium Nv |
Pullulan capsules
|
WO2018189587A1
(en)
|
2017-04-14 |
2018-10-18 |
Capsugel Belgium Nv |
Process for making pullulan
|
MX2019011446A
(es)
|
2017-05-09 |
2019-11-18 |
Nestle Sa |
Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños con fines de salud.
|
AU2018272764A1
(en)
|
2017-05-24 |
2019-10-24 |
Societe Des Produits Nestle S.A. |
HMOs blends for use in infants or young children for health purposes
|
AU2018274637A1
(en)
|
2017-05-24 |
2019-09-26 |
Societe Des Produits Nestle S.A. |
Composition comprising oligofructose (OF) for use in the improvement of short term memory and other cognitive benefits
|
EP3629769A1
(de)
|
2017-05-24 |
2020-04-08 |
Société des Produits Nestlé S.A. |
Zusammensetzung mit menschlichen milcholigosacchariden (hmo) zur verwendung bei der verbesserung des kurzzeitgedächtnisses und für andere kognitive nutzen
|
MX2020007198A
(es)
|
2017-12-21 |
2020-09-03 |
Nestle Sa |
Composiciones que comprenden al menos un oligosacarido n-acetilado y al menos uno fucosilado para usar en la promocion de la capacidad digestiva en infantes y niños pequeños.
|
CN111479573A
(zh)
|
2017-12-21 |
2020-07-31 |
雀巢产品有限公司 |
用于促进肠道肌肉生长和发育以及相关联的肠道能动性的组合物
|
MX2020007197A
(es)
|
2017-12-22 |
2020-09-03 |
Nestle Sa |
Composiciones para usar en la reduccion de la nocicepcion en infantes y niños pequeños.
|
EP3809878A1
(de)
|
2018-06-25 |
2021-04-28 |
Société des Produits Nestlé S.A. |
Zusammensetzung mit menschlichen milcholigosacchariden zur verwendung bei der verbesserung, verstärkung, förderung oder modulation einer serotonergen funktion im zentralnervensystem
|
AU2019296553A1
(en)
|
2018-06-25 |
2020-11-19 |
Societe Des Produits Nestle S.A. |
Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
|
EP3650044A1
(de)
*
|
2018-11-06 |
2020-05-13 |
ETH Zürich |
Anti-glykan-impfstoffe
|
MX2021005668A
(es)
|
2018-11-30 |
2021-06-15 |
Nestle Sa |
Composicion nutricional infantil para usar en el mejoramiento de la maduracion pancreatica y la biosintesis de insulina.
|
AU2019411483A1
(en)
|
2018-12-21 |
2021-06-03 |
Societe Des Produits Nestle S.A. |
A nutritional composition comprising 2'-Fucosyllactose (2' FL) to improve the gastrointestinal barrier
|
US20220287349A1
(en)
|
2018-12-21 |
2022-09-15 |
Societe Des Produits Nestle S.A. |
A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function
|
US20220079988A1
(en)
|
2018-12-21 |
2022-03-17 |
Societe Des Produits Nestle S.A. |
A nutritional composition comprising metabolites of hmos to improve the gastrointestinal barrier
|
WO2020178362A1
(en)
|
2019-03-05 |
2020-09-10 |
Société des Produits Nestlé S.A. |
A nutritional composition for use to enhance executive function
|
JP2022541757A
(ja)
*
|
2019-07-08 |
2022-09-27 |
クラポード バイオ,インコーポレイテッド |
リポオリゴ糖組成物およびワクチンの製造および使用方法
|
WO2021074374A1
(en)
|
2019-10-17 |
2021-04-22 |
Société des Produits Nestlé S.A. |
Extensively hydrolysed infant formula
|
AU2020367247A1
(en)
|
2019-10-17 |
2022-03-24 |
Société des Produits Nestlé S.A. |
Infant formula
|
MX2022006838A
(es)
|
2019-12-11 |
2022-07-11 |
Nestle Sa |
Composiciones para usar en la reduccion de la nocicepcion y otros beneficios para la salud en infantes y niños pequeños.
|
BR112022010083A2
(pt)
|
2019-12-30 |
2022-09-06 |
Nestle Sa |
Fórmula para bebês
|
BR112023005888A2
(pt)
|
2020-10-16 |
2023-05-02 |
Nestle Sa |
Fórmula para bebês ou crianças pequenas
|
CN116261398A
(zh)
|
2020-10-16 |
2023-06-13 |
雀巢产品有限公司 |
包含人乳低聚糖的营养组合物
|
EP4243634A1
(de)
|
2020-11-10 |
2023-09-20 |
Société des Produits Nestlé S.A. |
Ernährungszusammensetzung
|
WO2022129556A1
(en)
|
2020-12-18 |
2022-06-23 |
Société des Produits Nestlé S.A. |
Compositions for use in promoting accelerated butyrate production in young children
|
AU2022301175A1
(en)
|
2021-06-29 |
2024-01-04 |
Société des Produits Nestlé S.A. |
Bifidobacterium longum transitional microorganisms, compositions and uses thereof
|
WO2023237306A1
(en)
|
2022-06-09 |
2023-12-14 |
Dsm Ip Assets B.V. |
Nutritional composition comprising gos and hmos
|